trial
as of 2026-07-01Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders
NCTId NCT07395206
at a glance
— · Recruiting
Enrollment 60 (estimated)
Sponsored by Charite University, Berlin, Germany
Primary completion 2026-06-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Recruiting
Enrollment
60 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2026-01-30
Primary completion
2026-06-30
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Charite University, Berlin, GermanyLead Sponsor
Kiso Health GmbHCollaborator
Sites
1 total
Berlin, Germany
Facts & assertions
4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2026-06-30
Status
RECRUITING
relationships
The graph out of here
drug
lead_sponsor
collaborator
company
indication